ITC's net profit rose 7.37% to Rs 2560.50 crore on 4.41% growth in total income to Rs 14277.19 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
ICICI Bank's net profit fell 8.21% to Rs 2049 crore on 0.52% growth in total income to Rs 16847.04 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
ONGC's net profit fell 8.22% to Rs 3884.73 crore on 6.36% increase in total income to Rs 19927.93 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
Idea Cellular reported consolidated net loss of Rs 814.90 crore in Q1 June 2017 compared with net profit of Rs 220.40 crore in Q1 June 2016. Total income fell 14.34% to Rs 8181.70 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
Dr Reddy's Laboratories and CHD Bioscience Inc., a privately-held biopharmaceutical company, announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy's phase III clinical trial candidate, DFA-02. The announcement was made after market hours yesterday, 27 July 2017.
It is intended to be used for the prevention of surgical site infections, following non-emergency, elective colorectal surgery. Phase II studies for DFA-02 have been successfully completed, and the product will be transitioning to pivotal Phase III registration studies.
Under the terms of the agreement, Dr Reddy's would receive equity in CHD valued at $30 million upon an IPO of CHD or a minimum of $30 million in cash within 18 months of execution of the agreement. Dr. Reddy's will also receive additional milestone payments of $40 million upon USFDA approval. In addition, CHD will pay Dr. Reddy's double-digit royalties on sales and commercial milestones.
Biocon's consolidated net profit dropped 51.2% to Rs 81.30 crore on 4.2% fall in total income to Rs 985.50 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
Glenmark Pharmaceuticals' consolidated net profit surged 47.01% to Rs 333.38 crore on 16.28% rise in total income to Rs 2378.29 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
Reliance Capital's consolidated net profit surged rose 14.98% to Rs 238 crore on 32.6% rise in total income to Rs 4857 crore in Q1 June 2017 over Q1 June 2016. The result was announced after market hours yesterday, 27 July 2017.
Mindtree announced its advancement to business partner within the Adobe Solution Partner Program. The announcement was made after market hours yesterday, 27 July 2017.
This reflects Mindtree's specialization in Adobe Experience Manager, part of Adobe Experience Cloud, and its sustained focus to provide clients with comprehensive offerings, leveraging Adobe Experience Cloud for customer experience transformation.
The board of Advanced Enzyme Technologies will meet on 5 August 2017, to consider and approve raising of funds of the company, by way of qualified institutional placement route. The announcement was made after market hours yesterday, 27 July 2017.
Nava Bharat Ventures announced that the 300 megawatts (MW) power plant of Maamba Collieries, the step-down subsidiary of the company, has been in operation and has now achieved the provisional acceptance under the engineering procurement construction contract. Following the capitalization of the 300 MW power project upon provisional acceptance, its commercial operations will be consolidated in the company's financials henceforth. The announcement was made after market hours yesterday, 27 July 2017.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
